GlassScriptPhysician profile
Aref Wappi
NPI 1023026184
$1,600.81
in general payments reported to CMS, 2019-2025
16 companies · $98.18 in 2025
The $98.18 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $53.66 · 2021: $177 · 2022: $317 · 2023: $554 · 2024: $264 · 2025: $98.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.44 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $377.07 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $308.39 | 2021-2023 | Farxiga, Breztri |
| Amarin Pharma, INC. | $170.35 | 2019-2022 | |
| Lilly USA, LLC | $128.89 | 2022-2025 | Mounjaro, Emgality, Jardiance |
| Lundbeck LLC | $127.48 | 2023-2025 | Rexulti |
| Amgen INC. | $100.71 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $90.62 | 2019-2022 | |
| Exact Sciences Corporation | $68.72 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $48.13 | 2023 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $43.66 | 2019-2023 | |
| Esperion Therapeutics, INC. | $35.86 | 2024-2025 | Nexletol |
| Sumitomo Pharma America, INC. | $24.66 | 2024 | Gemtesa |
| Paratek Pharmaceuticals, INC. | $22.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.52 | 2019 | |
| Novo Nordisk INC | $18.16 | 2024 | Ozempic, Rybelsus |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $15.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aref Wappi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.